Search clinical trials for: Nimesulide Pantoprazole

Total 458 results

Takeda

Completed

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

Gastric Ulcers | Duodenal Ulcers

Japan
Advanced Center for Specialty Care
Takeda

Unknown

Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy

Laryngopharyngeal Reflux | Hypertrophy of Lingual Tonsil

United States
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

Gastroesophageal Reflux Disease
Takeda

Completed

Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs

Duodenal Ulcer | Stomach Ulcer

Japan
Takeda

Completed

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

Gastric Ulcers | Duodenal Ulcers

Japan
Takeda

Completed

A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

Gastroesophageal Reflux

United States
Takeda

Completed

Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
Takeda

Completed

Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Eli Lilly and Company

Completed

A Study of LY2940680 in Healthy Participants

Healthy Participants

United States
Zahra Vahdat Shariatpanahi

Completed

Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Helicobacter Infection

Iran, Islamic Republic of
Takeda

Completed

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Osteoarthritis | Peptic Ulcer
Boehringer Ingelheim

Completed

Bioavailability of BIBR 953 ZW in Healthy Subjects

Healthy
American University of Beirut Medical Center
AstraZeneca

Completed

The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

Calcium Metabolism Disorders

Lebanon
Klemens Budde
Novartis Pharmaceuticals

Completed

Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

Immunosuppression | Transplantation | Drug Interaction

Germany
The Christie NHS Foundation Trust
University of Manchester

Withdrawn

A Proof of Concept, Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer (IMpALA)

Breast Cancer
Takeda

Completed

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Healthy

United States
Takeda

Completed

Effect of Dexlansoprazole on Bone Homeostasis

Bone and Bones | Homeostasis

United States
University of Karachi
SAMI Pharmaceutical, Karachi Pakistan

Completed

Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. (BABE)

Healthy | Bioequivalence Study

Pakistan
Rigshospitalet, Denmark

Terminated

Stereotactic Radiosurgery in Metastatic Spinal Cord Compression (Stereocord)

Neoplasm Metastasis | Spinal Cord Compression

Denmark
Akdeniz University

Completed

Comparison of Pantoprazole and Ranitidine in Dyspepsia

Dyspepsia

Turkey
Sanofi
Bristol-Myers Squibb

Completed

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects

Healthy

United States
Ramathibodi Hospital

Completed

Once Daily Dose Dexlansoprazole Quadruple Therapy for Helicobacter Pylori

H Pylori Eradication

Thailand
University of Rochester
Takeda Pharmaceuticals North America, Inc.

Terminated

Effect of Antireflux Therapy on the Expression of Genes in Patients With GERD

Gastroesophageal Reflux | GERD

United States
Takeda

Completed

Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy Participants

Bioavailability

United States
Takeda

Completed

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Gastroesophageal Reflux

United States
Seoul National University Bundang Hospital

Completed

Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?

Antiplatelet Effect

Korea, Republic of
YongChan Lee
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis (REPAIR)

Gastroesophageal Reflux

Korea, Republic of, China
Debiopharm International SA

Completed

A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers

Bacterial Infections

United States
Eli Lilly and Company

Completed

A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Boehringer Ingelheim

Completed

Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects

Healthy
Takeda

Completed

Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis

Esophagitis, Peptic | Esophagitis, Reflux

United States
Janssen Research & Development, LLC

Completed

A Study to Assess the Effects of Acid-Reducing Agent(s) on JNJ-64417184 in Healthy Participants

Healthy Participants

Netherlands
Takeda

Completed

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Gastric or Duodenal Ulcers
Chinese University of Hong Kong

Completed

PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers

Peptic Ulcer

China
Takeda

Completed

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Gastric Ulcers | Duodenal Ulcers

Japan
Takeda

Completed

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

Gastric Ulcers | Duodenal Ulcers

Japan
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); American Lung Association...

Completed

Lansoprazole to Treat Children With Asthma (SARCA)

Asthma

United States
University of Alberta
Juvenile Diabetes Research Foundation

Completed

Incretin Effect and Use After Clinical Islet Transplantation

Type 1 Diabetes

Canada
HK inno.N Corporation

Completed

Pharmacodynamic Properties of CJ-12420 on Evening Dosing

Healthy

Korea, Republic of
Children's Mercy Hospital Kansas City

Recruiting

Effect of Obesity on Proton Pump Inhibitors (LiverLabPPI)

Pediatric Obesity | GERD | NAFLD

United States
University of Bari

Recruiting

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection. (THD-HP)

Helicobacter Pylori Infection | Antibiotic Resistant Infection | Antibiotic Resistant Strain

Italy
Sohag University

Not yet recruiting

Evaluation of Risk Factors and Outcome of Thrombosis in Children

Thrombosis in Children

Egypt
Takeda

Terminated

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

Duodenal Ulcer | Stomach Ulcer

Japan
Takeda

Completed

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Gastric or Duodenal Ulcers
Seoul National University Bundang Hospital
Green Cross Corporation; Chong Kun Dang Pharmaceutical; SK Chemicals Co., Ltd.; HK inno.N Corporation

Completed

Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

Helicobacter Pylori Infection

Korea, Republic of
Northern Orthopaedic Division, Denmark
Association of Danish Physiotherapists; The Danish Rheumatism Association

Completed

Structured Non-operative Treatment of Knee Osteoarthritis

Osteoarthritis of the Knee

Denmark
University of California, San Francisco

Completed

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

Type 2 Diabetes Mellitus

United States
Kaohsiung Veterans General Hospital.
Kaohsiung Medical University Chung-Ho Memorial Hospital

Completed

Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection (REHYTRI)

Helicobacter Pylori Infection

Taiwan
Loma Linda University

Withdrawn

The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux (ETDLPR)

Laryngopharyngeal Reflux | Eustachian Tube Dysfunction

United States

3

Subscribe